To further assess the prediction that low CDK5RAP3 levels promote tumor chemoresistance, we computed the expression correlation between CDK5RAP3 and previously defined signatures of chemoresistance and/or DNA damage resistance using breast cancer data from The Cancer Genome Atlas [31]. The gene discussed is CDK5RAP3; the disease is breast carcinoma.